About us

M42 is an Abu Dhabi-based, global tech-enabled healthcare company operating at the forefront of medical advancement. The company is seeking to transform lives through innovative clinical solutions that can solve the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is transforming the traditional healthcare ecosystem and delivering the highest level of precise, patient-centric, and preventative care. M42 has over 20,000 employees and more than 450 facilities in 26 countries around the world. M42 owns a wide portfolio of assets that includes Amana Healthcare, Biogenix Labs, Danat Al Emarat, Diaverum, HealthPoint Hospital, the HealthPlus network of specialty centers, Moorfields Eye Hospital Abu Dhabi, Imperial College London Diabetes Centre, Insights Research Organization & Solutions (IROS), Omics Center of Excellence and National Reference Laboratory, among others.

Website
https://m42.ae/
Industry
Hospitals and Health Care
Company size
10,001+ employees
Type
Privately Held

Employees at M42 Health

Updates

  • View organization page for M42 Health, graphic

    42,899 followers

    As part of #M42’s unwavering commitment towards safeguarding public health and studying environmental problems, we’re bringing our expertise in AI and technology, in partnership with Abu Dhabi Quality and Conformity Council, to launch the first-ever Honey Quality Laboratory. This innovative partnership works to ensure the UAE’s honey is free from adulterants and contaminants, setting new standards for the industry. By leveraging our state-of-the-art tech solutions and scalable capabilities, we are ensuring high-quality produce while indirectly fostering biodiversity through vital data and real-time insights. Read the full press release on the M42 website here: https://bit.ly/45NetWF

  • View organization page for M42 Health, graphic

    42,899 followers

    Join us for the third session of our Transplant #FocusOn series as we explore how to overcome the challenges of a heart transplant. Get expert insights from Dr. Mitesh V. Badiwala as he explores common complications following transplants and the best current management techniques to combat rejection and graft dysfunction. Register for the session on Thursday, 11th July from 3–4 PM: https://bit.ly/3XUhySN

    • No alternative text description for this image
  • View organization page for M42 Health, graphic

    42,899 followers

    The Abu Dhabi Biobank, a landmark initiative by #M42 and the Department of Health Abu Dhabi, aims to transform the region’s clinical landscape by creating a foundational, diverse bio-asset to support next-generation stem cell therapies. With their ability to renew, regenerate, and preserve human tissue, stem cells act as a “bio repair kit”. By cryopreserving and storing these cells as part of cord blood banking, they can be accessed at a later time and possess remarkable potential for the treatment of complex diseases. By offering both private and public banking options, the cord blood bank, as part of Abu Dhabi Biobank is a groundbreaking initiative and strategic priority that aims to shorten waiting times for treatment, increase therapeutic access for patients, improve survival rates and reduce the economic burden on governments. Learn more, by calling 800 213 or emailing cordblood@m42.ae 

  • View organization page for M42 Health, graphic

    42,899 followers

    Discover insights surrounding the role of interventional radiology in musculoskeletal disorders during the seventh session of our dedicated #FocusOn series! Join Dr. Muhammad Imran, Dr. Umme Sara Zishan, Dr. Ahmed Hamza, and Dr. Davoud Khodatars as they outline the latest techniques in image-guided interventions and their benefits. Register now for the session on Wednesday, 26th June from 3–4 PM: https://bit.ly/3VCELWX

    • No alternative text description for this image
  • View organization page for M42 Health, graphic

    42,899 followers

    Join esteemed industry pioneer Ashish Ipe Koshy, Group Chief Operating Officer of #M42, and discover how AI is reshaping the future of personalized health. From advanced diagnostics to streamlined patient services, witness how M42 is deploying next-generation technology that encompasses every aspect of clinical care. Watch the full panel discussion on our YouTube channel - https://bit.ly/4beHP17

Affiliated pages

Similar pages